Epirubicin and Medroxyprogesterone Acetate versus Estramustine Phosphate in Hormone-Resistant Prostatic Cancer: A Prospective Randomized Study (Q72014999)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 January 1995
edit
Language Label Description Also known as
English
Epirubicin and Medroxyprogesterone Acetate versus Estramustine Phosphate in Hormone-Resistant Prostatic Cancer: A Prospective Randomized Study
scientific article published on 01 January 1995

    Statements

    Epirubicin and medroxyprogesterone acetate versus estramustine phosphate in hormone-resistant prostatic cancer: a prospective randomized study (English)
    Epirubicin and Medroxyprogesterone Acetate versus Estramustine Phosphate in Hormone-Resistant Prostatic Cancer: A Prospective Randomized Study (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit